block further down, and Blade's raw-block scanner pairs an // inline β€” swallowing 140 lines of the article. $isDraftPreview = $isDraftPreview ?? false; @endphp Wegovy Price in Pakistan 2026: Real Costs Explained
πŸ’΅ Cash on Delivery available  Β·  πŸ’Š Pakistan's first physician-guided GLP-1 drops  Β·  ⚑ Sublingual fast-absorption technology  Β·  🏭 GMP-compliant manufacturing  Β·  πŸ“¦ 2–5 business day delivery  Β·  πŸ’΅ Cash on Delivery available  Β·  πŸ’Š Pakistan's first physician-guided GLP-1 drops  Β·  ⚑ Sublingual fast-absorption technology  Β·  🏭 GMP-compliant manufacturing  Β·  πŸ“¦ 2–5 business day delivery  Β· 
Medication & Safety

Wegovy Price in Pakistan: What It Really Costs in 2026

Medically reviewed Dr. Saad Mahmood MBBS, FCPS (Endocrinology)
Share

What Wegovy actually costs in Pakistan, why prices swing so much, the hidden costs nobody mentions, and the affordable GLP-1 options available locally.

Wegovy costs considerably more in Pakistan than most people expect, and the sticker price is only part of the total. Because Wegovy has no official registered launch here, every unit reaches the country through import channels, and that shapes everything about what you pay.

This guide breaks down the real cost structure, the parts that catch people out, and what the honest alternatives look like if the numbers do not work for your household.

Why there is no single Wegovy price

Wegovy is the higher-dose weight management version of semaglutide, made by Novo Nordisk. In countries where it is officially launched, there is a published list price and a regulated supply chain.

Pakistan does not have that. What circulates here comes through personal imports, informal channels, and small-scale medical suppliers. Each has different costs, different markups and different reliability.

This is why you will see wildly different figures quoted. There is no official number to anchor to. The price you are given depends entirely on who is selling and what their supply cost was that month.

Three things push the price around:

The exchange rate. Every imported unit is priced in dollars or euros first. When the rupee weakens, the price here rises within weeks.

Supply availability. Global semaglutide demand has repeatedly outstripped production. When international supply tightens, prices in unofficial markets rise sharply.

Chain length. The more hands a package passes through before reaching you, the more markup accumulates.

The realistic monthly range

Imported GLP-1 injections in Pakistan generally fall in the range of Rs 20,000 to Rs 50,000 per month. Wegovy sits at the upper end of that range because it is a weight-management-dose product rather than a diabetes dose.

The dose escalation schedule matters here. Wegovy starts at 0.25 mg weekly and steps up roughly every four weeks to a maintenance dose of 2.4 mg. Higher doses cost more. Your month-one cost is not your month-five cost.

A full course is not a one-month purchase either. Clinical use runs for many months. In the STEP 1 trial published in the New England Journal of Medicine, the 14.9 percent average weight loss was measured over 68 weeks. That is well over a year of continuous treatment.

Multiply the monthly figure by that duration and the true commitment becomes clear.

The costs nobody quotes you

The injection price is the part people compare. It is not the part that surprises them.

Physician consultation. Private clinics in Karachi, Lahore and Islamabad charge roughly Rs 2,000 to Rs 5,000 for an initial consultation. Follow-up visits during dose escalation add more.

Cold chain delivery. Semaglutide must stay refrigerated. Proper cold-chain shipping costs money, and cheap sellers who skip it are selling you a product that may have lost potency in transit.

Baseline testing. Responsible prescribing usually means blood work before you start and periodically after.

Supply gap losses. This is the one that genuinely hurts. If your supplier cannot source your next dose, your course breaks. Appetite returns, and the weeks you paid for lose much of their value. Restarting often means re-escalating the dose from a lower point.

Sharps disposal and supplies. Minor, but real.

Add these up and the effective monthly cost is often 20 to 40 percent above the quoted injection price.

The counterfeit problem

Where demand outstrips legal supply, counterfeits follow. This is not a theoretical risk in Pakistan.

Fake semaglutide pens have been found in multiple markets globally. Some contain insulin instead, which is dangerous. Some contain nothing active at all. Some contain the right drug at the wrong concentration.

You cannot identify a counterfeit by looking at it. Packaging is copied convincingly.

The practical rule is simple. If a seller cannot show you a verifiable import trail, cannot confirm cold-chain handling, and takes payment in advance through a personal account, treat the product as unverified regardless of how professional the presentation looks.

What the money actually buys

It is worth being clear about this, because cost-only comparisons mislead.

Wegovy works. The trial evidence is strong and the average results are substantially better than older weight loss medications. Nobody should pretend otherwise.

The question is not whether it works. The question is whether a treatment you cannot reliably obtain, cannot afford across a full course, and cannot verify the authenticity of is the right choice for your situation.

An interrupted GLP-1 course delivers a fraction of the benefit of a continuous one. Affordability and reliability are not separate from effectiveness. They determine it.

The locally registered option

This access gap is the reason registered sublingual options exist in this market at all.

If you are comparing the GLP-1 drops price in Pakistan against imported injection costs, the differences are structural rather than cosmetic. METASLIMβ„’ is physician-reviewed, so there is a verifiable quality process. It is sublingual, held under the tongue, so there is no cold chain to break and no injection to schedule. A physician reviews every order before dispatch, and that review is built into the program price rather than charged separately as a clinic consultation.

It is not pharmaceutical semaglutide, and it should not be presented as such. It is GLP-1 pathway support through a different delivery route, priced for a market where the imported option is out of reach for most households.

For a wider view of the field, our breakdown of what Ozempic costs covers the pricing structure of the diabetes-dose product, and the Pakistan access guide explains what is realistically obtainable here. You can also compare the full range of weight loss treatments available in Pakistan in one place.

How to think about the decision

Work out the total, not the monthly figure. Take the quoted price, add consultation and delivery, then multiply across the number of months you would realistically need.

Then ask the harder question. Can you sustain that for the full duration, through exchange rate swings and supply gaps? A course you abandon at month three costs you the money and returns very little.

If the total works, Wegovy is a strong option where you can obtain it verifiably. If it does not, a treatment you can actually complete beats a better treatment you cannot.

Before committing either way, check the current price and what's included so you are comparing complete programs rather than headline numbers.

This article is for informational purposes only and does not constitute medical advice. Consult a qualified physician before starting any weight loss program, medication, or supplement.

Physician-Guided Program

Ready to work with your hunger hormones, not against them?

METASLIMβ„’ is a physician-guided GLP-1 sublingual program β€” injection-free appetite support, designed for sustainable weight loss.

Order METASLIM™ →

References & Sources

  1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1), NEJM 2021

Frequently Asked Questions

There is no official Pakistani price because Wegovy has no registered launch here. Imported GLP-1 injections generally range from Rs 20,000 to Rs 50,000 per month, with Wegovy at the higher end. The exact figure depends on the exchange rate, current global supply and how many intermediaries handled the shipment.

Wegovy is not registered for sale in Pakistan. Units available here arrive through personal import or informal supply channels. This means there is no regulated price, no guaranteed supply continuity, and no straightforward recourse if the product turns out to be counterfeit or improperly stored.

Three factors drive the swings. The rupee-to-dollar exchange rate changes the import cost directly. Global semaglutide supply shortages push unofficial market prices up. And the number of intermediaries between manufacturer and buyer varies by seller, with each adding markup.

Consultation fees of Rs 2,000 to Rs 5,000, cold-chain delivery charges, baseline blood work, and repeat visits during dose escalation. The largest hidden cost is a broken supply chain, because an interrupted course loses much of its benefit and often requires restarting at a lower dose.

You generally cannot tell by appearance, because packaging is copied convincingly. Warning signs are a seller who cannot show a verifiable import trail, no evidence of refrigerated handling, and advance payment demanded through a personal account. Counterfeit semaglutide has been found containing insulin or no active ingredient at all.

Physician-reviewed sublingual GLP-1 supplements are available locally at a fraction of imported injection costs. They are not pharmaceutical semaglutide and should not be described as equivalent. They provide GLP-1 pathway support without cold-chain storage, injections, or dependence on an import supply that frequently breaks.

Clinical trials measured results over 68 weeks, which is more than a year of continuous treatment. Weight regain is common after stopping, so many people use it long term. When budgeting, multiply the monthly cost across the full duration rather than treating it as a one-month purchase.

Written by

Ayesha Tariq

Medical Content Writer

Ayesha is a Karachi-based health writer specialising in metabolic health and evidence-based nutrition for South Asian readers.

Medically reviewed by

Dr. Saad Mahmood

MBBS, FCPS (Endocrinology)

Dr. Mahmood is a consultant endocrinologist with a decade of experience managing obesity and type 2 diabetes.

← Back to Health Blog Start the Program →
METASLIMβ„’
4.9/5
Physician-guided formula
πŸ’΅ Cash on Delivery Contact Us